Edgewise Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Edgewise Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • Edgewise Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 94.4M shares, a 48.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 94.4M +30.9M +48.8% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 93.6M +30.2M +47.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 93.3M +30M +47.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 70.5M +7.2M +11.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 63.5M +252K +0.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 63.5M +13.7M +27.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 63.3M +13.7M +27.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 63.3M +13.8M +27.8% Dec 31, 2022 10-K 2024-02-22
Q3 2022 63.2M +13.9M +28.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 49.8M +518K +1.05% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 49.6M +302K +0.61% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 49.5M +48.5M +4804% Dec 31, 2021 10-K 2023-02-23
Q3 2021 49.3M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 49.3M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 49.3M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 1.01M Dec 31, 2020 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.